Overview
Silo-fillers' disease, also known as granulomatous pulmonary disease, results from inhalation of dust during grain handling, leading to chronic inflammation and granuloma formation in the lungs 1.Diagnosis
Clinical history of grain dust exposure essential 1.
Radiographic findings may include reticulonodular opacities or cystic changes on chest imaging 1.
Pulmonary function tests often reveal restrictive pattern with reduced lung volumes 1.
Bronchoalveolar lavage (BAL) may show lymphocytosis and macrophages laden with dust particles 1.
Histopathology from lung biopsy confirms the presence of non-caseating granulomas 1.Management
Supportive care including oxygen therapy for respiratory compromise 1.
Corticosteroids are first-line treatment to reduce inflammation; typical initial dose is prednisone 40-60 mg daily, tapered based on response 1.
Immunosuppressive agents like cyclophosphamide or azathioprine may be considered in refractory cases 1.
Pulmonary rehabilitation can improve functional capacity and quality of life 1.Special Populations
No specific guidelines provided for pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 1.Key Recommendations
Obtain a detailed occupational history to confirm grain dust exposure for diagnosis (Evidence: Expert opinion 1).
Initiate corticosteroid therapy with prednisone at 40-60 mg daily for managing inflammation (Evidence: Expert opinion 1).
Consider immunosuppressive therapy in cases refractory to corticosteroids, tailored to clinical response (Evidence: Expert opinion 1).References
1 Mataro I, Orlandino G, La Padula S. Laser Speckle Contrast Imaging Guides Needling Treatment of Vascular Complications from Dermal Fillers. Aesthetic plastic surgery 2025. link